(Q34615607)

3 August 2017

1 reference

title

Lamotrigine update and its use in mood disorders (English)

1 reference

3 August 2017

1 reference

Stephen C Hurley

1

1 reference

3 August 2017

language of work or name

English

0 references

publication date

1 May 2002

1 reference

Annals of Pharmacotherapy

3 August 2017

published in

1 reference

3 August 2017

volume

36

1 reference

3 August 2017

issue

5

1 reference

3 August 2017

page(s)

860-873

1 reference

Relapse and impairment in bipolar disorder

3 August 2017

cites work

1 reference

Safety review of adult clinical trial experience with lamotrigine

21 January 2018

1 reference

An in vitro investigation of the action of lamotrigine on neuronal voltage-activated sodium channels

21 January 2018

1 reference

Cellular and molecular actions of lamotrigine: Possible mechanisms of efficacy in bipolar disorder

21 January 2018

1 reference

Lamotrigine inhibition of glutamate release from isolated cerebrocortical nerve terminals (synaptosomes) by suppression of voltage-activated calcium channel activity

21 January 2018

1 reference

Lamotrigine inhibits monoamine uptake in vitro and modulates 5-hydroxytryptamine uptake in rats

21 January 2018

1 reference

Serum concentrations of lamotrigine in epileptic patients: the influence of dose and comedication.

21 January 2018

1 reference

Antidepressants for the new millennium

21 January 2018

1 reference

Antidepressant effects of ketamine in depressed patients

21 January 2018

1 reference

Attenuation of the neuropsychiatric effects of ketamine with lamotrigine: support for hyperglutamatergic effects of N-methyl-D-aspartate receptor antagonists.

21 January 2018

1 reference

Population pharmacokinetics of lamotrigine adjunctive therapy in adults with epilepsy.

21 January 2018

1 reference

Lamotrigine: pharmacokinetics

21 January 2018

1 reference

Population pharmacokinetics of lamotrigine monotherapy in patients with epilepsy: retrospective analysis of routine monitoring data

21 January 2018

1 reference

Sodium valproate acutely inhibits lamotrigine metabolism

21 January 2018

1 reference

Comparison of the pharmacokinetics of lamotrigine in patients with chronic renal failure and healthy volunteers

21 January 2018

1 reference

Structural and functional studies of UDP-glucuronosyltransferases

21 January 2018

1 reference

Lamotrigine and therapeutic drug monitoring: retrospective survey following the introduction of a routine service

21 January 2018

1 reference

Bidirectional interaction of valproate and lamotrigine in healthy subjects.

21 January 2018

1 reference

Lamotrigine toxicity secondary to sertraline

21 January 2018

1 reference

Lamotrigine plasma levels reduced by oral contraceptives

21 January 2018

1 reference

Lamotrigine in the treatment of schizoaffective disorder

21 January 2018

1 reference

Clinical studies on the use of lamotrigine in bipolar disorder.

21 January 2018

1 reference

A Double-Blind, Placebo-Controlled, Prophylaxis Study of Lamotrigine in Rapid-Cycling Bipolar Disorder

21 January 2018

1 reference

A placebo-controlled study of lamotrigine and gabapentin monotherapy in refractory mood disorders

21 January 2018

1 reference

An open study of lamotrigine in refractory bipolar depression.

21 January 2018

1 reference

The anticonvulsant lamotrigine in treatment-resistant manic-depressive illness.

21 January 2018

1 reference

Lamotrigine for the treatment of bipolar disorder: a clinical case series.

21 January 2018

1 reference

An open longitudinal study of patients with bipolar rapid cycling treated with lithium or lamotrigine for mood stabilization

21 January 2018

1 reference

A comparison of observational studies and randomized, controlled trials

21 January 2018

1 reference

Placebos, drug effects, and study design: a clinician's guide

21 January 2018

1 reference

Stable weight during lamotrigine therapy: a review of 32 studies

21 January 2018

1 reference

Lamotrigine-associated rash: risk/benefit considerations in adults and children

21 January 2018

1 reference

Safety of long-term lamotrigine in epilepsy

21 January 2018

1 reference

Acute granulomatous interstitial nephritis and colitis in anticonvulsant hypersensitivity syndrome associated with lamotrigine treatment

21 January 2018

1 reference

Acute hepatitis after lamotrigine administration

21 January 2018

1 reference

Factors Influencing the Incidence of Lamotrigine-Related Skin Rash

21 January 2018

1 reference

Risk of serious cutaneous disorders after initiation of use of phenytoin, carbamazepine, or sodium valproate: a record linkage study

21 January 2018

1 reference

Risk of Stevens-Johnson syndrome and toxic epider mal necrolysis during first weeks of antiepileptic therapy: a case-control study

21 January 2018

1 reference

Medication use and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis

21 January 2018

1 reference

Cognitive effects of topiramate, gabapentin, and lamotrigine in healthy young adults.

21 January 2018

1 reference

Behavioral and cognitive effects of lamotrigine

21 January 2018

1 reference

Effects of lamotrigine on nocturnal sleep, daytime somnolence and cognitive functions in focal epilepsy.

21 January 2018

1 reference

Lamotrigine associated with insomnia

21 January 2018

1 reference

Re: Sadler's article regarding lamotrigine-associated insomnia in an adult tertiary care epilepsy out-patient clinic

21 January 2018

1 reference

Positive and negative psychotropic effects of lamotrigine in patients with epilepsy and mental retardation.

21 January 2018

1 reference

The effects of phenytoin on impulsive and premeditated aggression: a controlled study

21 January 2018

1 reference

Differential sensitivity of recombinant GABA(A) receptors expressed in Xenopus oocytes to modulation by topiramate

21 January 2018

1 reference

Treatment of bipolar depression, a review of the literature and a suggestion for an algorithm

21 January 2018

1 reference

A double-blind comparison of lamotrigine and carbamazepine in newly diagnosed epilepsy with health-related quality of life as an outcome measure.

21 January 2018

1 reference

Olanzapine compared to lithium in mania: a double-blind randomized controlled trial

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1345/APH.1A102

1 reference

3 August 2017

1 reference